1,999
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Two types of immune infiltrating cells and six hub genes can predict the occurrence of myasthenia gravis in patients with thymoma

, , , , , , , , & ORCID Icon show all
Pages 5004-5016 | Received 12 Apr 2021, Accepted 17 Jul 2021, Published online: 08 Oct 2021

References

  • Scorsetti M, Leo F, Trama A, et al. Thymoma and thymic carcinomas. Crit Rev Oncol Hematol. 2016;99:332–350.
  • Remes-Troche JM, Téllez-Zenteno JF, Estañol B, et al. Thymectomy in myasthenia gravis: response, complications, and associated conditions. Arch Med Res. 2002;33(6):545–551.
  • Gilhus NE, Longo DL. Myasthenia Gravis. N Engl J Med. 2016;375(26):2570–2581.
  • Shintani Y, Funaki S, Ose N, et al. Surgical management of thymic epithelial tumors. Surg Today. 2021;51(3):331–339.
  • Howard JF Jr. Myasthenia gravis: the role of complement at the neuromuscular junction. Ann N Y Acad Sci. 2018;1412(1):113–128.
  • Berrih-Aknin S, Ragheb S, Le Panse R, et al. Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis. Autoimmun Rev. 2013;12(9):885–893.
  • Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457.
  • Rohr-Udilova N, Klinglmüller F, Schulte-Hermann R, et al. Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma. Sci Rep. 2018;8(1):6220.
  • Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.
  • Jia A, Xu L, Wang Y. Venn diagrams in bioinformatics. Brief Bioinform. 2021. DOI:10.1093/bib/bbab108
  • Xu F, Zhang Z, Yuan M, et al. M6A regulatory genes play an important role in the prognosis, progression and immune microenvironment of pancreatic adenocarcinoma. Cancer Invest. 2021;39(1):39–54.
  • Han H, Cho JW, Lee S, et al. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 2018;46(D1):D380–380D386.
  • Li H, Chen L, Ma X, et al. Shared gene expression between multiple sclerosis and ischemic stroke. Front Genet. 2018;9:598.
  • Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–509W514.
  • Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–607D613.
  • Zhao S, Ding J, Wang S, et al. Decreased expression of circulating air and increased Tfh/Tfr cells in myasthenia gravis patients. Biosci Rep. 2018;38(6). DOI:10.1042/BSR20180096.
  • Yang Y, Zhang M, Ye Y, et al. High frequencies of circulating Tfh-Th17 cells in myasthenia gravis patients. Neurol Sci. 2017;38(9):1599–1608.
  • Zhang M, Zhou Y, Guo J, et al. Thymic TFH cells involved in the pathogenesis of myasthenia gravis with thymoma. Exp Neurol. 2014;254:200–205.
  • Zhang X, Liu S, Chang T, et al. Intrathymic Tfh/B Cells interaction leads to ectopic GCs formation and Anti-AChR antibody production: central role in triggering MG occurrence. Mol Neurobiol. 2016;53(1):120–131.
  • Nagane Y, Utsugisawa K, Akutsu H, et al. Perivascular infiltrate of memory lymphocytes and mature dendritic cells in MG thymomas. Neurology. 2005;65(5):770–772.
  • Kalyanasundaram Bhanumathy K, Zhang B, Xie Y, et al. Potent immunotherapy against well-established thymoma using adoptively transferred transgene IL-6-engineered dendritic cell-stimulated CD8+ T-cells with prolonged survival and enhanced cytotoxicity. J Gene Med. 2015;17(8–9):153–160.
  • Ruthard J, Hermes G, Hartmann U, et al. Identification of antibodies against extracellular matrix proteins in human osteoarthritis. Biochem Biophys Res Commun. 2018;503(3):1273–1277.
  • Neumann E, Hasseli R, Lange U, et al. The role of extracellular nucleic acids in rheumatoid arthritis. Curr Pharm Biotechnol. 2018;19(15):1182–1188.
  • Herrero-Sánchez MC, Rodríguez-Serrano C, Almeida J, et al. Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development. J Hematol Oncol. 2016;9(1):113.
  • Ye X, Ong N, An H, et al. The emerging roles of NDR1/2 in infection and inflammation. Front Immunol. 2020;11:534.
  • Son S, Hwang I, Han SH, et al. Advanced glycation end products impair NLRP3 inflammasome–mediated innate immune responses in macrophages. J Biol Chem. 2017;292(50):20437–20448.
  • Dubuissez M, Loison I, Paget S, et al. Protein kinase C-mediated phosphorylation of BCL11B at Serine 2 negatively regulates its interaction with NuRD complexes during CD4+ T-cell activation. Mol Cell Biol. 2016;36(13):1881–1898.
  • Kim BS, Kim JK, Kang CH, et al. An immunohistochemical panel consisting of EZH2, C-KIT, and CD205 is useful for distinguishing thymic squamous cell carcinoma from type B3 thymoma. Pathol Res Pract. 2018;214(3):343–349.
  • Li QR, Ni WP, Lei NJ, et al. The overexpression of Fra1 disorders the inflammatory cytokine secretion by mTEC of myasthenia gravis thymus. Scand J Immunol. 2018;88(1):e12676.
  • Gong B, Wang X, Li B, et al. miR-205-5p inhibits thymic epithelial cell proliferation via FA2H-TFAP2A feedback regulation in age-associated thymus involution. Mol Immunol. 2020;122:173–185.